Monday, October 28, 2013
GreenEarthMeds News and Reviews: Top seven natural cures for cancer that got buried...
GreenEarthMeds News and Reviews: Top seven natural cures for cancer that got buried...: How do you keep the spread of cancer "growing"? Bury the cure. How do you keep 1.5 million Americans "infested" yearly ...
Top seven natural cures for cancer that got buried by the FDA, AMA, CDC!
How do you keep the spread of cancer "growing"? Bury the cure. How do
you keep 1.5 million Americans "infested" yearly with mutated cells that
multiply uncontrollably? You breed cancer in food and medicine. How
many years ago did America start this evil strategy to make people sick
and deny them the cure? Nearly 100 years. Where did it all really start?
The American Medical Association (AMA) and a man named Morris Fishbein,
who single-handedly removed nutrition from medical schools in the U.S.
and installed a fake seal of approval for harmful lab-made drugs that
made cancer worse. What else did Fishbein do? Just in case you "doubters" and skeptics want some concrete proof, some evidence to take with you on your journey NOT to get cancer, here are some historical, proven facts to help you understand WHY you need to go 100% organic and research and use natural remedies, to build your immunity to disease with superfoods, herbs, tinctures and organic supplements.
Let's begin this journey of truth and the not-so-healthy history of medicine in this bold country we call the "Land of the Free." Let's begin with the TOP SEVEN CURES for cancer that mainstream media will never admit to, because their advertising money comes from Big Pharma, the GMO Agriculture giants (Monsanto/Dupont/Bayer/Dow Chemical/etc.) and the lobbyists and politicians who make their money off of stocks in cancer therapies that don't work:
1. The AMA once paid a cancer virus researcher $250K to retire in Mexico and stop working on natural cures:
2. Burzynski documentary reveals true agenda of FDA and cancer industry to destroy cancer cures that really work:
3. 'Dying to Have Known' documentary features Gerson Therapy natural cancer cure:
4. Harry Hoxsey: Guilty of Curing Cancer with Herbs:
5. Magic mushrooms could treat depression, but clinical trials unnecessarily delayed by drug laws:
6. Marijuana - A cure for cancer?
7. Beat cancer with 35% hydrogen peroxide!
Pay it forward 100 years
Nearly 100 years ago, the AMA began removing nutritional education from medical schools in America. Medical doctors would no longer understand anything about using food as medicine (or be allowed to suggest it), and all mid-wives, Native American herbalists and natural healers would be referred to in medical journals as "quacks." The Western Medicine philosophy would soon come to be that no food in the world could ever heal a human being or cure any disease or disorder; in fact, only pharmaceuticals and vaccines would ever be able to make that claim (legally) and get away with it, whether in peer reviews, medical and science journals (JAMA), scientific "studies" or labeled as such on products.Currently, it is illegal for any food, herb, tincture or superfood product to say that it cures anything, yet medications advertised on TV since 1997 can say they treat all kinds of diseases and disorders, even though the side effects are horrendous, some of the time including internal bleeding and suicide.
Mother Nature, on the other hand, has a CURE for everything and also offers prevention and immunity for everything under the sun. Nutritionists and Naturopathic Physicians will tell you all day that organic fruits and vegetables are the key to healing and living a healthy life. A plant-based diet can heal nearly any health problem, and the body is like a machine that fires "on all cylinders" when given the correct fuel. Take this knowledge and be on your way to health freedom and natural living, where you have lots of energy, rarely ever get sick, can think critically all the time, can be spiritual and independent and take care of your family! Follow Natural News and track the truth. Learn and grow from it. Don't eat cancer. Don't drink cancer. Be organic.
Thursday, October 24, 2013
GreenEarthMeds News and Reviews: Top 4 Herbal ADD/ADHD Remedies Your Doctor Forgot ...
GreenEarthMeds News and Reviews: Top 4 Herbal ADD/ADHD Remedies Your Doctor Forgot ...: According to the Women’s International Summit for Health (WISH) (Summit starts October 28th), six million children have been diagnosed wi...
Top 4 Herbal ADD/ADHD Remedies Your Doctor Forgot to Mention! Wonder Why?
According to the Women’s International Summit for Health (WISH)
(Summit starts October 28th), six million children have been diagnosed
with Attention Deficit Disorder (ADD). Furthermore, the Attention
Deficit Disorder Association says that about 85% of adults are not aware
that they have Attention Deficit Hyperactivity Disorder (ADHD).
Symptoms include restlessness, inability to concentrate, difficulty
organizing tasks and becoming easily distracted by outside stimuli. For
most people with ADD/ADHD, work and social life is negatively impacted
due to missed tasks, forgotten agendas and a seemingly uninterested,
disruptive attitude.
To keep such symptoms at bay, doctors typically prescribe a litany of medications such as Ritalin, Adderall and Zoloft. However, like many medications, adverse side effects may include bladder and/or back pain, bloody urine and irregular heartbeat. While some people may find comfort in such medications, it’s important to know that there are herbal remedies that can help diminish ADD/ADHD symptoms, without the harmful side effects.
1. Gotu Kola: This herb has been known to produce additional neurotransmitters and contributes to enhanced blood flow which can increase mental function and improve the ability to concentrate.
2. Gingko Biloba: Used by many for their belief that it improves brain function immensely (it may even be effective in helping diminish the effects of Alzheimer’s disease), Gingko biloba plays a critical role in delivering blood and blood sugars to the brain and certain nerve cells.
3. Ginseng: ADHD is often associated with deficits in dopamine-related neurological pathways. Studies show ginseng compounds can combat this deficiency, helping expedite neurodevelopment and also contributing to improved communication between neuronal cells. It’s often used for alertness and to improve concentration.
4. Valerian: According to the University of Maryland Medical Center (UMMC), valerian can be given to as a treatment for ADHD. Valerian has been said to promote relaxation and more restful sleep in individuals, without drowsiness that can impair one’s abilities.
To keep such symptoms at bay, doctors typically prescribe a litany of medications such as Ritalin, Adderall and Zoloft. However, like many medications, adverse side effects may include bladder and/or back pain, bloody urine and irregular heartbeat. While some people may find comfort in such medications, it’s important to know that there are herbal remedies that can help diminish ADD/ADHD symptoms, without the harmful side effects.
Top Four Herbal Remedies to Help Decrease ADD/ADHD Symptoms
It’s not unusual for children and adults to be given a variety of these medications, often too freely. In an effort to move away from this harmful, sometimes fatal trend, many people seek the benefits of herbal treatments to diminish the symptoms of ADD/ADHD.1. Gotu Kola: This herb has been known to produce additional neurotransmitters and contributes to enhanced blood flow which can increase mental function and improve the ability to concentrate.
2. Gingko Biloba: Used by many for their belief that it improves brain function immensely (it may even be effective in helping diminish the effects of Alzheimer’s disease), Gingko biloba plays a critical role in delivering blood and blood sugars to the brain and certain nerve cells.
3. Ginseng: ADHD is often associated with deficits in dopamine-related neurological pathways. Studies show ginseng compounds can combat this deficiency, helping expedite neurodevelopment and also contributing to improved communication between neuronal cells. It’s often used for alertness and to improve concentration.
4. Valerian: According to the University of Maryland Medical Center (UMMC), valerian can be given to as a treatment for ADHD. Valerian has been said to promote relaxation and more restful sleep in individuals, without drowsiness that can impair one’s abilities.
GreenEarthMeds News and Reviews: Do You Still Believe Cholesterol Causes Cardiac Pr...
GreenEarthMeds News and Reviews: Do You Still Believe Cholesterol Causes Cardiac Pr...: A meta-analysis of properly performed previous studies on heart health and saturated fats concluded there was no association between cardi...
Do You Still Believe Cholesterol Causes Cardiac Problems? Don’t!
A meta-analysis of properly performed previous studies on heart
health and saturated fats concluded there was no association between
cardiac issues and saturated fats. This was published in the American
Journal of Clinical Nutrition (AJCN) on January 13th, 2010.
The AJCN meta-analysis covered studies involving 350,000 subjects who were followed for 5 to 23 years.
The saturated fat high cholesterol disinformation over the last few decades has resulted in many Americans eating and drinking more low and no fat foods and beverages. Yet, heart disease rates have continued to rise along with obesity.
Dr. William Davis asserts in his article “A Headline You Will Never See: 60 Year Old Man Dies of Cholesterol” that cholesterol doesn’t kill “any more than a bad paint job on your car could cause a fatal car accident.”
Dr. Davis explains the cause of most heart attacks, coronary problems and atherosclerosis is plaque from inflammation and calcium deposits, which can build up and rupture or clog the arteries. He and noted cardiologists Dr. Stephen Sinatra, Dr. Dwight Lundell, and other health practitioners have expressed the same viewpoint.
There can be some cholesterol in the plaque, but cholesterol itself is waxy and pliable. It’s even needed to help repair arterial damage. Cholesterol is important for brain matter, nerves and all other cellular structural components.
Calcium deposits (calcification) in artery interiors are much worse components of plaque. Calcium belongs in your bones and not in your arteries. Vitamin K2, magnesium, and vitamin D help transport calcium out of your blood and into your bones.
Dr. Davis recommends avoiding cholesterol panels for heart health concerns and opting for a measurement of coronary atherosclerosis plaque.
Many people with low cholesterol have died of coronary heart disease (CHD), while in their 40s, while many with high cholesterol never have CHD issues. Several studies of heart attack cadavers have also revealed the low instead of high cholesterol.
Statin drugs commonly prescribed for high cholesterol create earlier dementia risks and other unhealthy side effects while not reducing the risk for heart attack. But they rake in billions for Big Pharma.
Here’s How to Improve Heart Health without Pharmaceuticals
Cholesterol is vital for many functions. For example, it helps convert sunlight into vitamin D3, which helps prevent all sorts disease. Low cholesterol has been linked to higher stroke risks.
Oxidized cholesterol from hydrogenated and refined polyunsaturated cooking oils and margarine can lead to complications that result in CHD (coronary heart disease). This comes indirectly from the oxidation process those oils initiate.
Ironically, those toxic processed oils and butter substitutes were created to replace the wholesome saturated fats that were blamed for obesity and poor heart health. Instead, those healthy fats, unsaturated and saturated, should be consumed for good overall health.
Heart disease, cancer, and other chronic health issues have risen considerably even while many eagerly bought and consumed those low and no fat products that are often toxic.
Use plain whole milk yogurts, unsweetened, and add healthy honey instead. Get away from processed foods of all types, eliminate hydrogenated and partially hydrogenated oils, and decrease sugar and HFCS (high fructose corn syrup) intake while completely avoiding synthetic sugar substitutes.
Incorporate good fats such as organic cold pressed olive oils, avocado oil, coconut oil, and real butter into your diet. Eat lots of avocados while you’re at it. Very healthy. If you eat meat, reduce your meat consumption and use meats from free range grass fed livestock that are free from antibiotic and hormone injections instead.
This is important and easy: Nobel Prize winner Linus Pauling outlined this inexpensive supplement protocol years ago. Use it to both prevent heart health problems and even reverse them.
He recommended 2 grams of the inexpensive amino acid lysine or L-lysine oral supplements daily along with his recommended ascorbic acid levels of 3 grams. If one is at higher risk or has already had serious heart health issues, he recommended doubling those amounts.
These supplement and dietary approaches, along with reducing stress and some moderate exercise will do much more good for your heart health than taking statin drugs or other pharmaceuticals
The AJCN meta-analysis covered studies involving 350,000 subjects who were followed for 5 to 23 years.
The saturated fat high cholesterol disinformation over the last few decades has resulted in many Americans eating and drinking more low and no fat foods and beverages. Yet, heart disease rates have continued to rise along with obesity.
Dr. William Davis asserts in his article “A Headline You Will Never See: 60 Year Old Man Dies of Cholesterol” that cholesterol doesn’t kill “any more than a bad paint job on your car could cause a fatal car accident.”
Dr. Davis explains the cause of most heart attacks, coronary problems and atherosclerosis is plaque from inflammation and calcium deposits, which can build up and rupture or clog the arteries. He and noted cardiologists Dr. Stephen Sinatra, Dr. Dwight Lundell, and other health practitioners have expressed the same viewpoint.
There can be some cholesterol in the plaque, but cholesterol itself is waxy and pliable. It’s even needed to help repair arterial damage. Cholesterol is important for brain matter, nerves and all other cellular structural components.
Calcium deposits (calcification) in artery interiors are much worse components of plaque. Calcium belongs in your bones and not in your arteries. Vitamin K2, magnesium, and vitamin D help transport calcium out of your blood and into your bones.
Dr. Davis recommends avoiding cholesterol panels for heart health concerns and opting for a measurement of coronary atherosclerosis plaque.
Many people with low cholesterol have died of coronary heart disease (CHD), while in their 40s, while many with high cholesterol never have CHD issues. Several studies of heart attack cadavers have also revealed the low instead of high cholesterol.
Statin drugs commonly prescribed for high cholesterol create earlier dementia risks and other unhealthy side effects while not reducing the risk for heart attack. But they rake in billions for Big Pharma.
Here’s How to Improve Heart Health without Pharmaceuticals
Cholesterol is vital for many functions. For example, it helps convert sunlight into vitamin D3, which helps prevent all sorts disease. Low cholesterol has been linked to higher stroke risks.
Oxidized cholesterol from hydrogenated and refined polyunsaturated cooking oils and margarine can lead to complications that result in CHD (coronary heart disease). This comes indirectly from the oxidation process those oils initiate.
Ironically, those toxic processed oils and butter substitutes were created to replace the wholesome saturated fats that were blamed for obesity and poor heart health. Instead, those healthy fats, unsaturated and saturated, should be consumed for good overall health.
Heart disease, cancer, and other chronic health issues have risen considerably even while many eagerly bought and consumed those low and no fat products that are often toxic.
Use plain whole milk yogurts, unsweetened, and add healthy honey instead. Get away from processed foods of all types, eliminate hydrogenated and partially hydrogenated oils, and decrease sugar and HFCS (high fructose corn syrup) intake while completely avoiding synthetic sugar substitutes.
Incorporate good fats such as organic cold pressed olive oils, avocado oil, coconut oil, and real butter into your diet. Eat lots of avocados while you’re at it. Very healthy. If you eat meat, reduce your meat consumption and use meats from free range grass fed livestock that are free from antibiotic and hormone injections instead.
This is important and easy: Nobel Prize winner Linus Pauling outlined this inexpensive supplement protocol years ago. Use it to both prevent heart health problems and even reverse them.
He recommended 2 grams of the inexpensive amino acid lysine or L-lysine oral supplements daily along with his recommended ascorbic acid levels of 3 grams. If one is at higher risk or has already had serious heart health issues, he recommended doubling those amounts.
These supplement and dietary approaches, along with reducing stress and some moderate exercise will do much more good for your heart health than taking statin drugs or other pharmaceuticals
Sunday, October 13, 2013
GreenEarthMeds News and Reviews: Marijuana for Medical Use! We say Yes!
GreenEarthMeds News and Reviews: Marijuana for Medical Use! We say Yes!: Marijuana, or cannabis, as it is more appropriately called, has been part of humanity's medicine chest for almost as long as history ha...
Marijuana for Medical Use! We say Yes!
Marijuana, or cannabis, as it is more appropriately called, has been
part of humanity's medicine chest for almost as long as history has been
recorded.
Of all the negative consequences of marijuana prohibition, none is as tragic as the denial of medicinal cannabis to the tens of thousands of patients who could benefit from its therapeutic use.
Modern research suggests that cannabis is a valuable aid in the treatment of a wide range of clinical applications. These include pain relief -- particularly of neuropathic pain (pain from nerve damage) -- nausea, spasticity, glaucoma, and movement disorders. Marijuana is also a powerful appetite stimulant, specifically for patients suffering from HIV, the AIDS wasting syndrome, or dementia. Emerging research suggests that marijuana's medicinal properties may protect the body against some types of malignant tumors and are neuroprotective.
Currently, more than 60 U.S. and international health organizations support granting patients immediate legal access to medicinal marijuana under a physician's supervision.
Emerging Clinical Applications For Cannabis & Cannabinoids
A Review of the Recent Scientific Literature, 2000 — 2012
Humans have cultivated and consumed the flowering tops of the female cannabis plant, colloquially known as marijuana,
since virtually the beginning of recorded history. Cannabis-based
textiles dating to 7,000 B.C.E have been recovered in northern China,
and the plant's use as a medicinal and mood altering agent date back
nearly as far. In 2008, archeologists in Central Asia discovered over
two-pounds of cannabis in the 2,700-year-old grave of an ancient shaman.
After scientists conducted extensive testing on the material's
potency, they affirmed, "[T]he most probable conclusion ... is that
[ancient] culture[s] cultivated cannabis for pharmaceutical,
psychoactive, and divinatory purposes."
Modern cultures continue to indulge in the consumption of cannabis for these same purposes, despite a present-day, virtual worldwide ban on the plant's cultivation and use. In the United States, federal prohibitions outlawing cannabis' recreational, industrial, and therapeutic use were first imposed by Congress under the Marihuana Tax Act of 1937 and then later reaffirmed by federal lawmakers' decision to classify marijuana -- as well as all of the plant's organic compounds (known as cannabinoids) -- as a Schedule I substance under the Controlled Substances Act of 1970. This classification, which asserts by statute that cannabis is equally as dangerous to the public as is heroin, defines cannabis and its dozens of distinct cannabinoids as possessing 'a high potential for abuse, ... no currently accepted medical use, ... [and] a lack of accepted safety for the use of the drug ... under medical supervision.' (By contrast, cocaine and methamphetamine -- which remain illicit for recreational use but may be consumed under a doctor's supervision -- are classified as Schedule II drugs; examples of Schedule III and IV substances include anabolic steroids and Valium respectively, while codeine-containing analgesics are defined by a law as Schedule V drugs, the federal government's most lenient classification.) In July 2011, the Obama Administration rebuffed an administrative inquiry seeking to reassess cannabis' Schedule I status, and federal lawmakers continue to cite the drug's dubious categorization as the primary rationale for the government's ongoing criminalization of the plant and those who use it.
Nevertheless, there exists little if any scientific basis to justify the federal government's present prohibitive stance and there is ample scientific and empirical evidence to rebut it. Despite the US government's nearly century-long prohibition of the plant, cannabis is nonetheless one of the most investigated therapeutically active substances in history. To date, there are over 20,000 published studies or reviews in the scientific literature pertaining to the cannabis plant and its cannabinoids, nearly one-third of which were published within the last three years. This total includes over 2,700 separate papers published in 2009, 1,950 papers published in 2010, and another 2,100 published to date in 2011 (according to a key word search on the search engine PubMed Central, the US government repository for peer-reviewed scientific research). While much of the renewed interest in cannabinoid therapeutics is a result of the discovery of the endocannabinoid regulatory system (which we describe in detail later in this booklet), some of this increased attention is also due to the growing body of testimonials from medical cannabis patients and their physicians.
The scientific conclusions of the overwhelmingly majority of modern research directly conflicts with the federal government's stance that cannabis is a highly dangerous substance worthy of absolute criminalization.
For example, in February 2010 investigators at the University of California Center for Medicinal Cannabis Research publicly announced the findings of a series of randomized, placebo-controlled clinical trials on the medical utility of inhaled cannabis. The studies, which utilized the so-called 'gold standard' FDA clinical trial design, concluded that marijuana ought to be a "first line treatment" for patients with neuropathy and other serious illnesses.
Among the studies conducted by the Center, four assessed smoked marijuana's ability to alleviate neuropathic pain, a notoriously difficult to treat type of nerve pain associated with cancer, diabetes, HIV/AIDS, spinal cord injury and many other debilitating conditions. Each of the trials found that cannabis consistently reduced patients' pain levels to a degree that was as good or better than currently available medications.
Another study conducted by the Center's investigators assessed the use of marijuana as a treatment for patients suffering from multiple sclerosis. That study determined that "smoked cannabis was superior to placebo in reducing spasticity and pain in patients with MS, and provided some benefit beyond currently prescribed treatments."
Around the globe, similarly controlled trials are also taking place. A 2010 review by researchers in Germany reports that since 2005 there have been 37 controlled studies assessing the safety and efficacy of marijuana and its naturally occurring compounds in a total of 2,563 subjects. By contrast, many FDA-approved drugs go through far fewer trials involving far fewer subjects.
As clinical research into the therapeutic value of cannabinoids has proliferated so too has investigators' understanding of cannabis' remarkable capability to combat disease. Whereas researchers in the 1970s, 80s, and 90s primarily assessed cannabis' ability to temporarily alleviate various disease symptoms -- such as the nausea associated with cancer chemotherapy -- scientists today are exploring the potential role of cannabinoids to modify disease.
Of particular interest, scientists are investigating cannabinoids' capacity to moderate autoimmune disorders such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease, as well as their role in the treatment of neurological disorders such as Alzheimer's disease and amyotrophic lateral sclerosis (a.k.a. Lou Gehrig's disease.) In fact, in 2009, the American Medical Association (AMA) resolved for the first time in the organization's history "that marijuana's status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines."
Investigators are also studying the anti-cancer activities of cannabis, as a growing body of preclinical and clinical data concludes that cannabinoids can reduce the spread of specific cancer cells via apoptosis (programmed cell death) and by the inhibition of angiogenesis (the formation of new blood vessels). Arguably, these latter findings represent far broader and more significant applications for cannabinoid therapeutics than researchers could have imagined some thirty or even twenty years ago.
THE SAFETY PROFILE OF MEDICAL CANNABIS
Cannabinoids have a remarkable safety record, particularly when compared to other therapeutically active substances. Most significantly, the consumption of marijuana -- regardless of quantity or potency -- cannot induce a fatal overdose. According to a 1995 review prepared for the World Health Organization, "There are no recorded cases of overdose fatalities attributed to cannabis, and the estimated lethal dose for humans extrapolated from animal studies is so high that it cannot be achieved by ... users."
In 2008, investigators at McGill University Health Centre and McGill University in Montreal and the University of British Columbia in Vancouver reviewed 23 clinical investigations of medical cannabinoid drugs (typically oral THC or liquid cannabis extracts) and eight observational studies conducted between 1966 and 2007. Investigators "did not find a higher incidence rate of serious adverse events associated with medical cannabinoid use" compared to non-using controls over these four decades.
That said, cannabis should not necessarily be viewed as a 'harmless' substance. Its active constituents may produce a variety of physiological and euphoric effects. As a result, there may be some populations that are susceptible to increased risks from the use of cannabis, such as adolescents, pregnant or nursing mothers, and patients who have a family history of mental illness. Patients with hepatitis C, decreased lung function (such as chronic obstructive pulmonary disease), or who have a history of heart disease or stroke may also be at a greater risk of experiencing adverse side effects from marijuana. As with any medication, patients should consult thoroughly with their physician before deciding whether the medical use of cannabis is safe and appropriate.
HOW TO USE THIS REPORT
As states continue to approve legislation enabling the physician-supervised use of medical marijuana, more patients with varying disease types are exploring the use of therapeutic cannabis. Many of these patients and their physicians are now discussing this issue for the first time and are seeking guidance on whether the therapeutic use of cannabis may or may not be advisable. This report seeks to provide this guidance by summarizing the most recently published scientific research (2000-2012) on the therapeutic use of cannabis and cannabinoids for 20 clinical indications.
In some of these cases, modern science is now affirming longtime anecdotal reports of medical cannabis users (e.g., the use of cannabis to alleviate GI disorders). In other cases, this research is highlighting entirely new potential clinical utilities for cannabinoids (e.g., the use of cannabinoids to modify the progression of diabetes.)
The conditions profiled in this report were chosen because patients frequently inquire about the therapeutic use of cannabis to treat these disorders. In addition, many of the indications included in this report may be moderated by cannabis therapy. In several cases, preclinical data and clinical data indicate that cannabinoids may halt the advancement of these diseases in a more efficacious manner than available pharmaceuticals.
For patients and their physicians, this report can serve as a primer for those who are considering using or recommending medical cannabis. For others, this report can serve as an introduction to the broad range of emerging clinical applications for cannabis and its various compounds.
Of all the negative consequences of marijuana prohibition, none is as tragic as the denial of medicinal cannabis to the tens of thousands of patients who could benefit from its therapeutic use.
Modern research suggests that cannabis is a valuable aid in the treatment of a wide range of clinical applications. These include pain relief -- particularly of neuropathic pain (pain from nerve damage) -- nausea, spasticity, glaucoma, and movement disorders. Marijuana is also a powerful appetite stimulant, specifically for patients suffering from HIV, the AIDS wasting syndrome, or dementia. Emerging research suggests that marijuana's medicinal properties may protect the body against some types of malignant tumors and are neuroprotective.
Currently, more than 60 U.S. and international health organizations support granting patients immediate legal access to medicinal marijuana under a physician's supervision.
Recent Research on Medical Marijuana
Emerging Clinical Applications For Cannabis & Cannabinoids
A Review of the Recent Scientific Literature, 2000 — 2012
Foreword
Endocannabinoid System
Alzheimer's Disease
ALS
Chronic Pain
Diabetes Mellitus
Dystonia
Fibromyalgia
GI Disorders
Gliomas/Cancer
Hepatitis C
HIV
Huntington's Disease
Hypertension
Incontinence
MRSA
Multiple Sclerosis
Osteoporosis
Pruritus
Rheumatoid Arthritis
Sleep Apnea
Tourette's Syndrome
Endocannabinoid System
Alzheimer's Disease
ALS
Chronic Pain
Diabetes Mellitus
Dystonia
Fibromyalgia
GI Disorders
Gliomas/Cancer
Hepatitis C
HIV
Huntington's Disease
Hypertension
Incontinence
MRSA
Multiple Sclerosis
Osteoporosis
Pruritus
Rheumatoid Arthritis
Sleep Apnea
Tourette's Syndrome
Modern cultures continue to indulge in the consumption of cannabis for these same purposes, despite a present-day, virtual worldwide ban on the plant's cultivation and use. In the United States, federal prohibitions outlawing cannabis' recreational, industrial, and therapeutic use were first imposed by Congress under the Marihuana Tax Act of 1937 and then later reaffirmed by federal lawmakers' decision to classify marijuana -- as well as all of the plant's organic compounds (known as cannabinoids) -- as a Schedule I substance under the Controlled Substances Act of 1970. This classification, which asserts by statute that cannabis is equally as dangerous to the public as is heroin, defines cannabis and its dozens of distinct cannabinoids as possessing 'a high potential for abuse, ... no currently accepted medical use, ... [and] a lack of accepted safety for the use of the drug ... under medical supervision.' (By contrast, cocaine and methamphetamine -- which remain illicit for recreational use but may be consumed under a doctor's supervision -- are classified as Schedule II drugs; examples of Schedule III and IV substances include anabolic steroids and Valium respectively, while codeine-containing analgesics are defined by a law as Schedule V drugs, the federal government's most lenient classification.) In July 2011, the Obama Administration rebuffed an administrative inquiry seeking to reassess cannabis' Schedule I status, and federal lawmakers continue to cite the drug's dubious categorization as the primary rationale for the government's ongoing criminalization of the plant and those who use it.
Nevertheless, there exists little if any scientific basis to justify the federal government's present prohibitive stance and there is ample scientific and empirical evidence to rebut it. Despite the US government's nearly century-long prohibition of the plant, cannabis is nonetheless one of the most investigated therapeutically active substances in history. To date, there are over 20,000 published studies or reviews in the scientific literature pertaining to the cannabis plant and its cannabinoids, nearly one-third of which were published within the last three years. This total includes over 2,700 separate papers published in 2009, 1,950 papers published in 2010, and another 2,100 published to date in 2011 (according to a key word search on the search engine PubMed Central, the US government repository for peer-reviewed scientific research). While much of the renewed interest in cannabinoid therapeutics is a result of the discovery of the endocannabinoid regulatory system (which we describe in detail later in this booklet), some of this increased attention is also due to the growing body of testimonials from medical cannabis patients and their physicians.
The scientific conclusions of the overwhelmingly majority of modern research directly conflicts with the federal government's stance that cannabis is a highly dangerous substance worthy of absolute criminalization.
For example, in February 2010 investigators at the University of California Center for Medicinal Cannabis Research publicly announced the findings of a series of randomized, placebo-controlled clinical trials on the medical utility of inhaled cannabis. The studies, which utilized the so-called 'gold standard' FDA clinical trial design, concluded that marijuana ought to be a "first line treatment" for patients with neuropathy and other serious illnesses.
Among the studies conducted by the Center, four assessed smoked marijuana's ability to alleviate neuropathic pain, a notoriously difficult to treat type of nerve pain associated with cancer, diabetes, HIV/AIDS, spinal cord injury and many other debilitating conditions. Each of the trials found that cannabis consistently reduced patients' pain levels to a degree that was as good or better than currently available medications.
Another study conducted by the Center's investigators assessed the use of marijuana as a treatment for patients suffering from multiple sclerosis. That study determined that "smoked cannabis was superior to placebo in reducing spasticity and pain in patients with MS, and provided some benefit beyond currently prescribed treatments."
Around the globe, similarly controlled trials are also taking place. A 2010 review by researchers in Germany reports that since 2005 there have been 37 controlled studies assessing the safety and efficacy of marijuana and its naturally occurring compounds in a total of 2,563 subjects. By contrast, many FDA-approved drugs go through far fewer trials involving far fewer subjects.
As clinical research into the therapeutic value of cannabinoids has proliferated so too has investigators' understanding of cannabis' remarkable capability to combat disease. Whereas researchers in the 1970s, 80s, and 90s primarily assessed cannabis' ability to temporarily alleviate various disease symptoms -- such as the nausea associated with cancer chemotherapy -- scientists today are exploring the potential role of cannabinoids to modify disease.
Of particular interest, scientists are investigating cannabinoids' capacity to moderate autoimmune disorders such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease, as well as their role in the treatment of neurological disorders such as Alzheimer's disease and amyotrophic lateral sclerosis (a.k.a. Lou Gehrig's disease.) In fact, in 2009, the American Medical Association (AMA) resolved for the first time in the organization's history "that marijuana's status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines."
Investigators are also studying the anti-cancer activities of cannabis, as a growing body of preclinical and clinical data concludes that cannabinoids can reduce the spread of specific cancer cells via apoptosis (programmed cell death) and by the inhibition of angiogenesis (the formation of new blood vessels). Arguably, these latter findings represent far broader and more significant applications for cannabinoid therapeutics than researchers could have imagined some thirty or even twenty years ago.
THE SAFETY PROFILE OF MEDICAL CANNABIS
Cannabinoids have a remarkable safety record, particularly when compared to other therapeutically active substances. Most significantly, the consumption of marijuana -- regardless of quantity or potency -- cannot induce a fatal overdose. According to a 1995 review prepared for the World Health Organization, "There are no recorded cases of overdose fatalities attributed to cannabis, and the estimated lethal dose for humans extrapolated from animal studies is so high that it cannot be achieved by ... users."
In 2008, investigators at McGill University Health Centre and McGill University in Montreal and the University of British Columbia in Vancouver reviewed 23 clinical investigations of medical cannabinoid drugs (typically oral THC or liquid cannabis extracts) and eight observational studies conducted between 1966 and 2007. Investigators "did not find a higher incidence rate of serious adverse events associated with medical cannabinoid use" compared to non-using controls over these four decades.
That said, cannabis should not necessarily be viewed as a 'harmless' substance. Its active constituents may produce a variety of physiological and euphoric effects. As a result, there may be some populations that are susceptible to increased risks from the use of cannabis, such as adolescents, pregnant or nursing mothers, and patients who have a family history of mental illness. Patients with hepatitis C, decreased lung function (such as chronic obstructive pulmonary disease), or who have a history of heart disease or stroke may also be at a greater risk of experiencing adverse side effects from marijuana. As with any medication, patients should consult thoroughly with their physician before deciding whether the medical use of cannabis is safe and appropriate.
HOW TO USE THIS REPORT
As states continue to approve legislation enabling the physician-supervised use of medical marijuana, more patients with varying disease types are exploring the use of therapeutic cannabis. Many of these patients and their physicians are now discussing this issue for the first time and are seeking guidance on whether the therapeutic use of cannabis may or may not be advisable. This report seeks to provide this guidance by summarizing the most recently published scientific research (2000-2012) on the therapeutic use of cannabis and cannabinoids for 20 clinical indications.
In some of these cases, modern science is now affirming longtime anecdotal reports of medical cannabis users (e.g., the use of cannabis to alleviate GI disorders). In other cases, this research is highlighting entirely new potential clinical utilities for cannabinoids (e.g., the use of cannabinoids to modify the progression of diabetes.)
The conditions profiled in this report were chosen because patients frequently inquire about the therapeutic use of cannabis to treat these disorders. In addition, many of the indications included in this report may be moderated by cannabis therapy. In several cases, preclinical data and clinical data indicate that cannabinoids may halt the advancement of these diseases in a more efficacious manner than available pharmaceuticals.
For patients and their physicians, this report can serve as a primer for those who are considering using or recommending medical cannabis. For others, this report can serve as an introduction to the broad range of emerging clinical applications for cannabis and its various compounds.
Tuesday, October 8, 2013
GreenEarthMeds News and Reviews: Cancer-causing chemical found in nearly 100 common...
GreenEarthMeds News and Reviews: Cancer-causing chemical found in nearly 100 common...: If you use store-bought, conventionally-formulated shampoos, conditioners, body washes and other similar personal care products on a regul...
Cancer-causing chemical found in nearly 100 common soaps and shampoos! Here's What You Need To Know!
If you use store-bought, conventionally-formulated shampoos,
conditioners, body washes and other similar personal care products on a
regular basis, you could be exposing yourself to high doses of a
cancer-causing chemical that few people are even aware exists. The
Center for Environmental Health (CEH) recently published the findings of
an independent study it conducted which found that 98 tested shampoos,
soaps and other personal care products contained high levels of cocamide
diethanolamine (cocamide DEA), a hidden foaming and thickening agent
that is a known carcinogen.
Most GreenEarthMeds readers are probably already familiar with some of the other more well-known chemical culprits found in personal care products, which include things like petroleum-based parabens or sodium lauryl sulfate, for instance. Many companies have already voluntarily phased these and other "big name" chemicals out of their products to meet growing demand for clean, toxin-free products. But there are still a number of other harmful chemicals out there like cocamide DEA that continue to be used in prominent personal care product brands, including some that are marketed as "natural" and organic.
Perhaps not surprisingly, several large corporate brands, including Colgate Palmolive and Paul Mitchell, were identified in the study as manufacturing products that contain cocamide DEA. Other brands that might come as more of a surprise include a lemon-scented kitchen hand wash sold by Trader Joe's and a ginger shampoo made by a company known as "Organix." Other implicated brands include American Crew, Palmolive, Equate (Walmart), At One With Nature, Simple Pleasures and Moroccanoil,and Many More.
"Most people believe that products sold in major stores are tested for safety, but consumers need to know that they could be doused with a cancer-causing chemical every time they shower or shampoo," says Michael Green, executive director of CEH, about the new findings. "We expect companies to take swift action to end this unnecessary risk to our children's and families' health."
CEH recently sent letters to the nearly 100 companies it identified as still selling products that contain cocamide DEA, notifying them that their continued use of the chemical is a violation of California's Proposition 65, which pertains to cancer-causing chemicals. CEH has also reportedly filed lawsuits against Walgreens, Lake Consumer Products, Vogue International and Ultimark Products due to the presence of cocamide DEA in their products, with eventual plans to file lawsuits against the other 94 involved companies in the coming weeks and months.
"I don't think anybody wants to add one more thing to the list of cancer-causing chemicals that we're exposed to," says Caroline Cox, research director at CEH, as quoted by the San Francisco Gate. "There's lots of ways to make shampoo without it. This is one we don't really need."
Most GreenEarthMeds readers are probably already familiar with some of the other more well-known chemical culprits found in personal care products, which include things like petroleum-based parabens or sodium lauryl sulfate, for instance. Many companies have already voluntarily phased these and other "big name" chemicals out of their products to meet growing demand for clean, toxin-free products. But there are still a number of other harmful chemicals out there like cocamide DEA that continue to be used in prominent personal care product brands, including some that are marketed as "natural" and organic.
Perhaps not surprisingly, several large corporate brands, including Colgate Palmolive and Paul Mitchell, were identified in the study as manufacturing products that contain cocamide DEA. Other brands that might come as more of a surprise include a lemon-scented kitchen hand wash sold by Trader Joe's and a ginger shampoo made by a company known as "Organix." Other implicated brands include American Crew, Palmolive, Equate (Walmart), At One With Nature, Simple Pleasures and Moroccanoil,and Many More.
Companies still selling products with cocamide DEA in California are breaking the law
While labeling that indicates the presence of DEA is obviously required on personal care products, labeling that indicates levels of the chemical is not. This is problematic, especially in California where a law passed last year prohibits the chemical from being added to any products sold in the state beginning in June 2013. This ban came after the International Agency for Research on Cancer found that cocamide DEA can cause cancer in mammals."Most people believe that products sold in major stores are tested for safety, but consumers need to know that they could be doused with a cancer-causing chemical every time they shower or shampoo," says Michael Green, executive director of CEH, about the new findings. "We expect companies to take swift action to end this unnecessary risk to our children's and families' health."
CEH recently sent letters to the nearly 100 companies it identified as still selling products that contain cocamide DEA, notifying them that their continued use of the chemical is a violation of California's Proposition 65, which pertains to cancer-causing chemicals. CEH has also reportedly filed lawsuits against Walgreens, Lake Consumer Products, Vogue International and Ultimark Products due to the presence of cocamide DEA in their products, with eventual plans to file lawsuits against the other 94 involved companies in the coming weeks and months.
"I don't think anybody wants to add one more thing to the list of cancer-causing chemicals that we're exposed to," says Caroline Cox, research director at CEH, as quoted by the San Francisco Gate. "There's lots of ways to make shampoo without it. This is one we don't really need."
GreenEarthMeds News and Reviews: Breaking: Courts discreetly confirm MMR vaccine ca...
GreenEarthMeds News and Reviews: Breaking: Courts discreetly confirm MMR vaccine ca...: You won't hear anything about it from the mainstream media, but the federal government's kangaroo "vaccine court" has onc...
Breaking: Courts discreetly confirm MMR vaccine causes autism! Finally The Plain Truth!
You won't hear anything about it from the mainstream media, but the
federal government's kangaroo "vaccine court" has once again conceded,
albeit quietly, that the combination measles, mumps and rubella (MMR)
vaccine does, indeed, cause autism. In a recently published ruling, part
of which was censored from public view, a young boy was awarded
hundreds of thousands of dollars after it was determined that the MMR
vaccine led to a confirmed diagnosis of autism spectrum disorder (ASD).
Ten-year-old Ryan Mojabi's parents say he first suffered an encephalopathy after being vaccinated for MMR on December 19, 2003. Known as a "table injury," encephalopathy is a recognized, compensable adverse reaction to vaccines, and one that the kangaroo vaccine court has previously linked to vaccines. According to Ryan's parents, the MMR vaccine caused their son's encephalopathy, which manifested as "neuroimmunologically mediated dysfunctions in the form of asthma and ASD."
After being bumped around from court to court, Ryan's case was eventually heard by the vaccine court's Autism Omnibus Proceedings, according to The Huffington Post. And in the end, the federal government agreed that Ryan's encephalopathy had been caused by the MMR vaccine, a landmark ruling that confirms what Dr. Andrew Wakefield found more than 15 years ago when studying gut disorders in children given the MMR vaccine.
"Ryan suffered a Table injury under the Vaccine Act -- namely, an encephalitis within five to fifteen days following receipt (of MMR)," admitted the U.S. Department of Health and Human Services (HHS) regarding the case. "This case is appropriate for compensation," it added, in full agreement with the court's decision.
Of particular note in the case is the fact that concession documents by the government remain under seal. While the court and the government at large openly admitted that the MMR vaccine caused Ryan's encephalitis, it did not make public its opinion on whether or not that encephalitis led to Ryan's other injuries, including those that fall into the category of ASD. But the fact that these documents remain censored shows that the government is hiding something of importance from the public, which most definitely has to do with the connection between the MMR vaccine and autism.
These two cases, combined with numerous published studies out of the U.S., South America, and Europe, prove that the MMR vaccine is not the harmless vaccine that the conventional medical industry claims it is. In fact, everything that Dr. Wakefield found back in the late 1990s concerning the MMR vaccine -- findings that cost him his career and reputation, by the way -- are proving to be undeniably true.
"There can be very little doubt that vaccines can and do cause autism," Dr. Wakefield recently stated from his home in Austin, Texas. "In these children, the evidence for an adverse reaction involving brain injury following the MMR that progresses to an autism diagnosis is compelling. It's now a question of the body count. The parents' story was right all along. Governments must stop playing with words while children continue to be damaged. My hope is that recognition of the intestinal disease in these children will lead to the relief of their suffering. This is long, long overdue."
Ten-year-old Ryan Mojabi's parents say he first suffered an encephalopathy after being vaccinated for MMR on December 19, 2003. Known as a "table injury," encephalopathy is a recognized, compensable adverse reaction to vaccines, and one that the kangaroo vaccine court has previously linked to vaccines. According to Ryan's parents, the MMR vaccine caused their son's encephalopathy, which manifested as "neuroimmunologically mediated dysfunctions in the form of asthma and ASD."
After being bumped around from court to court, Ryan's case was eventually heard by the vaccine court's Autism Omnibus Proceedings, according to The Huffington Post. And in the end, the federal government agreed that Ryan's encephalopathy had been caused by the MMR vaccine, a landmark ruling that confirms what Dr. Andrew Wakefield found more than 15 years ago when studying gut disorders in children given the MMR vaccine.
"Ryan suffered a Table injury under the Vaccine Act -- namely, an encephalitis within five to fifteen days following receipt (of MMR)," admitted the U.S. Department of Health and Human Services (HHS) regarding the case. "This case is appropriate for compensation," it added, in full agreement with the court's decision.
Of particular note in the case is the fact that concession documents by the government remain under seal. While the court and the government at large openly admitted that the MMR vaccine caused Ryan's encephalitis, it did not make public its opinion on whether or not that encephalitis led to Ryan's other injuries, including those that fall into the category of ASD. But the fact that these documents remain censored shows that the government is hiding something of importance from the public, which most definitely has to do with the connection between the MMR vaccine and autism.
Concerned parents everywhere were right all along: MMR vaccine can cause autism
In a similar case heard during the same month, young Emily Moller from Houston, Texas, was also awarded massive compensation for injuries resulting from the MMR vaccine. According to reports, Emily experienced a severe reaction after receiving not only the MMR vaccine but also the DTaP (diphtheria, tetanus, and pertussis), HiB, and Prevnar vaccines. Like with Ryan's case, the government conceded that these vaccines led to Emily's autism and other developmental problems.These two cases, combined with numerous published studies out of the U.S., South America, and Europe, prove that the MMR vaccine is not the harmless vaccine that the conventional medical industry claims it is. In fact, everything that Dr. Wakefield found back in the late 1990s concerning the MMR vaccine -- findings that cost him his career and reputation, by the way -- are proving to be undeniably true.
"There can be very little doubt that vaccines can and do cause autism," Dr. Wakefield recently stated from his home in Austin, Texas. "In these children, the evidence for an adverse reaction involving brain injury following the MMR that progresses to an autism diagnosis is compelling. It's now a question of the body count. The parents' story was right all along. Governments must stop playing with words while children continue to be damaged. My hope is that recognition of the intestinal disease in these children will lead to the relief of their suffering. This is long, long overdue."
Subscribe to:
Posts (Atom)